Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

307 ARTíCULOS , VIENDO DEL 241 AL 255

PUBMED

Identifying modifiers of Huntington's disease progression.

Saft C.

Lancet Neurol. 2017 Sep;16(9):679-680. doi: 10.1016/S1474-4422(17)30179-5. Epub 2017 Jun 20. No abstract available.

0

0

0

PUBMED

NMR Spectroscopy-based Metabolomics of Drosophila Model of Huntington's Disease Suggests Altered Cell Energetics.

Singh V, Sharma RK, Athilingam T, Sinha P, Sinha N, Thakur AK.

J Proteome Res. 2017 Sep 26. doi: 10.1021/acs.jproteome.7b00491. [Epub ahead of print]

0

0

0

PUBMED

The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.

Ryskamp D, Wu J, Geva M, Kusko R, Grossman I, Hayden M, Bezprozvanny I.

Neurobiol Dis. 2017 Jan;97(Pt A):46-59. doi: 10.1016/j.nbd.2016.10.006.

0

0

0

PUBMED

Neuroimaging as a tool to study the sources of phenotypic heterogeneity in Huntington's disease.

Garcia-Gorro C, Camara E, de Diego-Balaguer R.

Curr Opin Neurol. 2017 May 15. doi: 10.1097/WCO.0000000000000461. [Epub ahead of print]

0

0

0

PUBMED

Predicting Prognosis of Psychosis in Huntington's Disease: Case Report and Review of Literature.

Kar SK, Shahi MK, Tripathi A, Sharma PK.

J Neurosci Rural Pract. 2017 Jul-Sep;8(3):469-471. doi: 10.4103/jnrp.jnrp_453_16.

0

0

0

PUBMED

l-Thyroxine-responsive drop attacks in childhood benign hereditary chorea: A case report.

Shiohama T, Ohashi H, Shimizu K, Fujii K, Oba D, Takatani T, Kato M, Shimojo N.

Brain Dev. 2017 Dec 27. pii: S0387-7604(17)30316-9. doi: 10.1016/j.braindev.2017.12.008. [Epub ahead of print]

0

0

0

PUBMED

Age of onset in Huntington's disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes.

Stuitje G, van Belzen MJ, Gardiner SL, van Roon-Mom WMC, Boogaard MW; REGISTRY Investigators of the European Huntington Disease Network., Tabrizi SJ, Roos RAC, Aziz NA.

Brain. 2017 May 25. doi: 10.1093/brain/awx122. [Epub ahead of print] No abstract available.

0

0

0

PUBMED

Depressed Synaptic Transmission and Reduced Vesicle Release Sites in Huntington's Disease Neuromuscular Junctions.

Khedraki A, Reed EJ, Romer SH, Wang Q, Romine W, Rich MM, Talmadge RJ, Voss AA.

J Neurosci. 2017 Jul 19. pii: 0313-17. doi: 10.1523/JNEUROSCI.0313-17.2017. [Epub ahead of print]

0

0

0

PUBMED

Predictors of Workplace Disability in a Premanifest Huntington's Disease Cohort.

Goh AMY, You E, Perin S, Clay FJ, Loi S, Ellis K, Chong T, Ames D, Lautenschlager N.

J Neuropsychiatry Clin Neurosci. 2017 Nov 29:appineuropsych17040086. doi: 10.1176/appi.neuropsych.17040086. [Epub ahead of print]

0

0

0

PUBMED

Is mitochondrial oxidative metabolism the right therapy target in early Huntington disease?

Lodi R.

Neurology. 2017 Jan 10;88(2):116-117. doi: 10.1212/WNL.0000000000003497. No abstract available.

0

0

0

PUBMED

Lithium Sensitive ORAI1 Expression, Store Operated Ca(2+) Entry and Suicidal Death of Neurons in Chorea-Acanthocytosis.

Pelzl L, Hauser S, Elsir B, Sukkar B, Sahu I, Singh Y, Höflinger P, Bissinger R, Jemaà M, Stournaras C, Schöls L, Lang F.

Sci Rep. 2017 Jul 25;7(1):6457. doi: 10.1038/s41598-017-06451-1.

0

0

0

PUBMED

The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington's disease.

Hernández IH, Torres-Peraza J, Santos-Galindo M, Ramos-Morón E, Fernández-Fernández MR, Pérez-Álvarez MJ, Miranda-Vizuete A, Lucas JJ.

Acta Neuropathol. 2017 Dec;134(6):839-850. doi: 10.1007/s00401-017-1770-2. Epub 2017 Aug 31.

0

0

0

PUBMED

The Effect of Music Therapy in Patients with Huntington's Disease: A Randomized Controlled Trial.

van Bruggen-Rufi MC, Vink AC, Wolterbeek R, Achterberg WP, Roos RA.

J Huntingtons Dis. 2017 Mar 15. doi: 10.3233/JHD-160229. [Epub ahead of print]

0

0

0

PUBMED

Risk factors for the onset and progression of Huntington disease.

Chao TK, Hu J, Pringsheim T.

Neurotoxicology. 2017 Jan 20. pii: S0161-813X(17)30016-5. doi: 10.1016/j.neuro.2017.01.005. [Epub ahead of print]

0

0

0

PUBMED

Treatment of Agitation in Huntington's Disease With Electroconvulsive Therapy.

Shah RP, Alluri V, Sharma S.

J Neuropsychiatry Clin Neurosci. 2017 Jan 25:appineuropsych16080161. doi: 10.1176/appi.neuropsych.16080161. [Epub ahead of print] No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy